Normal view
-
cs.AI, q-bio.NC updates on arXiv.org
-
World Models Unlock Optimal Foraging Strategies in Reinforcement Learning Agents
arXiv:2512.12548v1 Announce Type: new Abstract: Patch foraging involves the deliberate and planned process of determining the optimal time to depart from a resource-rich region and investigate potentially more beneficial alternatives. The Marginal Value Theorem (MVT) is frequently used to characterize this process, offering an optimality model for such foraging behaviors. Although this model has been widely used to make predictions in behavioral ecology, discovering the computational mechanisms
-
cs.AI, q-bio.NC updates on arXiv.org
-
Value-Aware Multiagent Systems
arXiv:2512.12652v1 Announce Type: new Abstract: This paper introduces the concept of value awareness in AI, which goes beyond the traditional value-alignment problem. Our definition of value awareness presents us with a concise and simplified roadmap for engineering value-aware AI. The roadmap is structured around three core pillars: (1) learning and representing human values using formal semantics, (2) ensuring the value alignment of both individual agents and multiagent systems, and (3) provi
Value-Aware Multiagent Systems
-
cs.AI, q-bio.NC updates on arXiv.org
-
Explainable AI as a Double-Edged Sword in Dermatology: The Impact on Clinicians versus The Public
arXiv:2512.12500v1 Announce Type: cross Abstract: Artificial intelligence (AI) is increasingly permeating healthcare, from physician assistants to consumer applications. Since AI algorithm's opacity challenges human interaction, explainable AI (XAI) addresses this by providing AI decision-making insight, but evidence suggests XAI can paradoxically induce over-reliance or bias. We present results from two large-scale experiments (623 lay people; 153 primary care physicians, PCPs) combining a fai
Explainable AI as a Double-Edged Sword in Dermatology: The Impact on Clinicians versus The Public
-
cs.AI, q-bio.NC updates on arXiv.org
-
Understanding Syllogistic Reasoning in LLMs from Formal and Natural Language Perspectives
arXiv:2512.12620v1 Announce Type: cross Abstract: We study syllogistic reasoning in LLMs from the logical and natural language perspectives. In process, we explore fundamental reasoning capabilities of the LLMs and the direction this research is moving forward. To aid in our studies, we use 14 large language models and investigate their syllogistic reasoning capabilities in terms of symbolic inferences as well as natural language understanding. Even though this reasoning mechanism is not a unif
Understanding Syllogistic Reasoning in LLMs from Formal and Natural Language Perspectives
-
cs.AI, q-bio.NC updates on arXiv.org
-
Building from Scratch: A Multi-Agent Framework with Human-in-the-Loop for Multilingual Legal Terminology Mapping
arXiv:2512.12950v1 Announce Type: cross Abstract: Accurately mapping legal terminology across languages remains a significant challenge, especially for language pairs like Chinese and Japanese, which share a large number of homographs with different meanings. Existing resources and standardized tools for these languages are limited. To address this, we propose a human-AI collaborative approach for building a multilingual legal terminology database, based on a multi-agent framework. This approac
Building from Scratch: A Multi-Agent Framework with Human-in-the-Loop for Multilingual Legal Terminology Mapping
-
cs.AI, q-bio.NC updates on arXiv.org
-
Privacy Ethics Alignment in AI: A Stakeholder-Centric Framework for Ethical AI
arXiv:2503.11950v4 Announce Type: replace-cross Abstract: The increasing integration of artificial intelligence (AI) in digital ecosystems has reshaped privacy dynamics, particularly for young digital citizens navigating data-driven environments. This study explores evolving privacy concerns across three key stakeholder groups-young digital citizens, parents/educators, and AI professionals-and assesses differences in data ownership, trust, transparency, parental mediation, education, and risk-b
Privacy Ethics Alignment in AI: A Stakeholder-Centric Framework for Ethical AI
-
cs.AI, q-bio.NC updates on arXiv.org
-
Generating Reliable Synthetic Clinical Trial Data: The Role of Hyperparameter Optimization and Domain Constraints
arXiv:2505.05019v2 Announce Type: replace-cross Abstract: The generation of synthetic clinical trial data offers a promising approach to mitigating privacy concerns and data accessibility limitations in medical research. However, ensuring that synthetic datasets maintain high fidelity, utility, and adherence to domain-specific constraints remains a key challenge. While hyperparameter optimization (HPO) improves generative model performance, the effectiveness of different optimization strategies
Generating Reliable Synthetic Clinical Trial Data: The Role of Hyperparameter Optimization and Domain Constraints
-
cs.AI, q-bio.NC updates on arXiv.org
-
Ethics Practices in AI Development: An Empirical Study Across Roles and Regions
arXiv:2508.09219v2 Announce Type: replace-cross Abstract: Recent advances in AI applications have raised growing concerns about the need for ethical guidelines and regulations to mitigate the risks posed by these technologies. In this paper, we present a mixed-methods survey study - combining statistical and qualitative analyses - to examine the ethical perceptions, practices, and knowledge of individuals involved in various AI development roles. Our survey comprises 414 participants from 43 co
Ethics Practices in AI Development: An Empirical Study Across Roles and Regions
-
cs.AI, q-bio.NC updates on arXiv.org
-
Grounding Large Language Models in Clinical Evidence: A Retrieval-Augmented Generation System for Querying UK NICE Clinical Guidelines
arXiv:2510.02967v3 Announce Type: replace-cross Abstract: This paper presents the development and evaluation of a Retrieval-Augmented Generation (RAG) system for querying the United Kingdom's National Institute for Health and Care Excellence (NICE) clinical guidelines using Large Language Models (LLMs). The extensive length and volume of these guidelines can impede their utilisation within a time-constrained healthcare system, a challenge this project addresses through the creation of a system
Grounding Large Language Models in Clinical Evidence: A Retrieval-Augmented Generation System for Querying UK NICE Clinical Guidelines
-
cs.AI, q-bio.NC updates on arXiv.org
-
Three Lenses on the AI Revolution: Risk, Transformation, Continuity
arXiv:2510.12859v2 Announce Type: replace-cross Abstract: Artificial Intelligence (AI) has emerged as both a continuation of historical technological revolutions and a potential rupture with them. This paper argues that AI must be viewed simultaneously through three lenses: \textit{risk}, where it resembles nuclear technology in its irreversible and global externalities; \textit{transformation}, where it parallels the Industrial Revolution as a general-purpose technology driving productivity an
Three Lenses on the AI Revolution: Risk, Transformation, Continuity
-
AI News

-
CEOs still betting big on AI: Strategy vs. return on investment in 2026
Enterprise leaders are pressing ahead with artificial intelligence, even as some early results remain uneven. Reporting from the Wall Street Journal and Reuters shows that most CEOs expect AI spending to keep rising through 2026, despite difficulty tying those investments to clear, enterprise-wide returns. The tension highlights where many organisations now sit in their AI journey. The technology has moved beyond trials and proofs of concept, but it has yet to settle into a reliable source of va
CEOs still betting big on AI: Strategy vs. return on investment in 2026
Enterprise leaders are pressing ahead with artificial intelligence, even as some early results remain uneven. Reporting from the Wall Street Journal and Reuters shows that most CEOs expect AI spending to keep rising through 2026, despite difficulty tying those investments to clear, enterprise-wide returns.
The tension highlights where many organisations now sit in their AI journey. The technology has moved beyond trials and proofs of concept, but it has yet to settle into a reliable source of value. Companies are operating in an in-between phase, where ambition, execution, and expectations are all under strain at the same time.
Spending continues, even as returns lag
AI budgets have climbed steadily in large enterprises over the past two years. Competitive pressure, board oversight, and fear of being left behind have all played a role. At the same time, executives are more open about the limits they are seeing. Gains often show up in pockets rather than in the business, pilots fail to spread, and the cost of connecting AI systems to existing tools keeps rising.
A Wall Street Journal survey of senior executives found that most CEOs see AI as central to long-term competitiveness, even if short-term benefits are hard to measure. For many, AI no longer feels optional. It is treated as a capability that must be developed over time, rather than a project that can be paused if results disappoint.
That view helps explain why spending remains steady. Leaders worry that cutting back now could weaken their position later, especially as rivals improve how they use the technology.
Why pilots struggle to scale
One of the main barriers to stronger returns is the jump from experimentation to day-to-day use. Many organisations have launched AI pilots in different teams, often without shared rules or coordination. While these efforts can generate insight and interest, few translate into changes that affect the wider business.
Reuters has reported that companies trying to scale AI frequently run into issues with data quality, system links, security controls, and regulatory requirements. The problems are not only technical, but reflect how work is organised. Responsibility is often split in teams, ownership is unclear, and decisions slow down once projects touch legal, risk, and IT functions.
The result is a pattern of heavy spending on trials, with limited progress toward systems that are embedded in core operations.
Infrastructure costs reshape the equation
The cost of infrastructure is also weighing on AI returns. Training and running models demands large amounts of computing power, storage, and energy. Cloud bills can rise quickly as use grows, while building on-site systems requires upfront investment and long planning cycles. Executives cited by Reuters have warned that infrastructure costs can outpace the benefits delivered by AI tools, particularly in the early stages. This has led to tough choices: whether to centralise AI resources or leave teams to experiment on their own; whether to build in-house systems or rely on vendors; and how much waste is acceptable while capabilities are still forming.
In practice, these decisions are shaping AI strategy as much as model performance or use-case selection.
AI governance moves to the centre of CEO decision-making
As AI spending increases, so does scrutiny. Boards, regulators, and internal audit teams are asking harder questions. In response, many organisations are tightening control. Decision rights are shifting toward central teams, AI councils are becoming more common, and projects are being linked more closely to business priorities.
The Wall Street Journal reports that companies are moving away from loosely connected experiments toward clearer goals, measures, and timelines. This can slow progress, but it reflects a growing belief that AI should be managed with the same discipline as other major investments.
The shift marks a change in how AI is treated. It is no longer a side effort or a curiosity but is being brought into existing operating and risk structures.
Expectations are being reset, not abandoned
Importantly, the persistence of AI spending does not signal blind optimism. Instead, it reflects a reset in expectations. CEOs are learning that AI rarely delivers immediate, sweeping returns. Value tends to emerge gradually, as organisations adjust workflows, retrain staff, and refine data foundations.
Rather than abandoning AI initiatives, many enterprises are narrowing their focus. They are prioritising fewer use cases, demanding clearer ownership, and aligning projects more closely with business outcomes. The re-calibration may reduce short-term excitement, but it improves the likelihood of sustainable returns.
What CEO AI strategy signals for 2026 planning
For organisations shaping their plans for 2026, the message for every CEO is not to retreat from AI, but to pursue it with more care as AI strategies mature. Ownership, governance, and realistic timelines matter more than headline spending levels or bold claims.
Those most likely to benefit are treating AI as a long-term shift in how the organisation works, not a quick route to growth. In the next phase, advantage will depend less on how much is spent and more on how well AI fits into everyday operations.
(Photo by Ambre Estève)
Want to learn more about AI and big data from industry leaders? Check out AI & Big Data Expo taking place in Amsterdam, California, and London. The comprehensive event is part of TechEx and co-located with other leading technology events. Click here for more information.
AI News is powered by TechForge Media. Explore other upcoming enterprise technology events and webinars here.
The post CEOs still betting big on AI: Strategy vs. return on investment in 2026 appeared first on AI News.
-
npj Digital Medicine
-
H&E-based MSI/MMR testing with AI in colorectal cancer: a multi-centred blinded evaluation
npj Digital Medicine, Published online: 15 December 2025; doi:10.1038/s41746-025-02218-5H&E-based MSI/MMR testing with AI in colorectal cancer: a multi-centred blinded evaluation
H&E-based MSI/MMR testing with AI in colorectal cancer: a multi-centred blinded evaluation
npj Digital Medicine, Published online: 15 December 2025; doi:10.1038/s41746-025-02218-5
H&E-based MSI/MMR testing with AI in colorectal cancer: a multi-centred blinded evaluation-
npj Digital Medicine
-
A randomized clinical trial of app cognitive behavior therapy vs. HealthWatch for obsessive compulsive disorder
npj Digital Medicine, Published online: 15 December 2025; doi:10.1038/s41746-025-02230-9A randomized clinical trial of app cognitive behavior therapy vs. HealthWatch for obsessive compulsive disorder
A randomized clinical trial of app cognitive behavior therapy vs. HealthWatch for obsessive compulsive disorder
npj Digital Medicine, Published online: 15 December 2025; doi:10.1038/s41746-025-02230-9
A randomized clinical trial of app cognitive behavior therapy vs. HealthWatch for obsessive compulsive disorder